Home › Medulloblastoma › Michigan › Ann Arbor
Medulloblastoma clinical trials in Ann Arbor, MI
3 studies for Medulloblastoma are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
RecruitingPhase 2
- C.S. MOTT Children's Hospital, University of Michigan, Ann Arbor
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
RecruitingPhase 3
- C S Mott Children's Hospital, Ann Arbor
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RecruitingPhase 2
- C.S. Mott Children's Hospital, Ann Arbor
Medulloblastoma trials in other cities
- Washington, DC9 studies
- St. Louis, MO6 studies
- Houston, TX4 studies
- New York City, NY4 studies
- Philadelphia, PA4 studies
- Miami, FL4 studies
- Seattle, WA4 studies
- Durham, NC4 studies
- Tampa, FL4 studies
- Memphis, TN3 studies
- Chicago, IL3 studies
- Columbus, OH3 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer26 studies
- Cancer (all types)25 studies
- Colorectal Cancer23 studies
- Lung Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.